作者: P. Blier , C. Montigny
DOI: 10.1007/978-3-642-71288-3_15
关键词:
摘要: Monoamine oxidase inhibitors (MAOIs) were the first effective drugs in treatment of major depression (Klein et al. 1980). Given their inhibiting action on catabolism monoaminergic neurotransmitters, they constitute unique tools for investigating neurobiological basis antidepressant response.